![Randall Schatzman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Randall Schatzman
Corporate Officer/Principal at
AlderBio Holdings LLC
Profile
Randall C.
Schatzman was the founder of Lundbeck Seattle BioPharmaceuticals, Inc. (2004) and served as President, Chief Executive Officer & Director from 2013 to 2018.
Current job includes Manager at AlderBio Holdings LLC.
Former jobs include Chief Executive Officer & Director at Bolt Biotherapeutics, Inc. (2019-2024), Director-Gene Discovery at Mercator Genetics, Inc. (1995-1999), Director at Vitaeris, Inc., Senior Vice President-Discovery Research at Celltech R&D, Inc., and Principal at Syntex, Inc. Education includes a doctorate from Emory University and an undergraduate degree from Purdue University.
Randall Schatzman active positions
| Companies | Position | Start |
|---|---|---|
AlderBio Holdings LLC | Corporate Officer/Principal | - |
Former positions of Randall Schatzman
| Companies | Position | End |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Chief Executive Officer | 15/05/2024 |
| ALDER BIOPHARMACEUTICALS, INC. | Founder | 20/03/2018 |
Mercator Genetics, Inc.
 Mercator Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene therapy programs for asthma, schizophrenia and cancer | Corporate Officer/Principal | 01/01/1999 |
Vitaeris, Inc.
 Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Director/Board Member | - |
Syntex, Inc.
 Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Corporate Officer/Principal | - |
Training of Randall Schatzman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
23
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Mercator Genetics, Inc.
Mercator Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene therapy programs for asthma, schizophrenia and cancer | Commercial Services |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Celltech R&D, Inc.
 Celltech R&D, Inc. Drugstore ChainsRetail Trade Provides research and development for pharmaceutical products | Retail Trade |
Syntex, Inc.
Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
AlderBio Holdings LLC | |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Randall Schatzman
